Blade Outboards Launches HALO Connect Mobile App for the 2026 Halo Series
ANNA MARIA ISLAND, Fla., March 6, 2026 /PRNewswire/ — Blade Outboards today announced the launch of Blade Halo Connect, a fully integrated mobile and web platform... Read more.
indē wild marks a new milestone for Indian beauty with Sephora US launch
MUMBAI, India, March 6, 2026 /PRNewswire/ — indē wild, the Ayurvedic‑inspired beauty brand co‑founded by global influencer and entrepreneur Diipa Büller‑Khosla,... Read more.
Aisa Pharma Announces Encouraging Results from Phase 2 RECONNOITER Trial of AISA-021 (Cilnidipine) in Patients with Systemic Sclerosis-Associated Raynaud’s Phenomenon
AISA-021 demonstrated a significant improvement in the number of attack-free days and a reduction in median weekly Raynaud’s attack frequency AISA-021 significantly... Read more.
HIMSS 2026: Artera to Showcase Real-World Applications of AI for Patient Communications and Access
In-Booth Sessions Showcase Artera’s Agentic AI Setting New Standards for Patient Access, New Insights from Signify Research on Voice AI for Patient Access,... Read more.
Aurelion Welcomes Its First AI Employee Duncan.Aure
HONG KONG, March 6, 2026 /PRNewswire/ — Aurelion (NASDAQ: AURE), the world’s first NASDAQ-listed Tether Gold (XAU₮) treasury company, today announced... Read more.
Trumid Reaches New ADV Milestone in February Amid Record Client Engagement
Accelerating list protocol activity drives 37% YoY ADV growth, with record overall and U.S. Investment Grade market share NEW YORK, March 6, 2026 /PRNewswire/ —... Read more.
U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression‑free survival and overall survival versus standard of care... Read more.
DiligenceSquared Raises $5M to Bring AI-Driven Commercial Due Diligence to Private Equity
New AI-native platform conducts expert interviews, synthesizes findings, and delivers fully traceable diligence reports traditionally produced by consulting firms... Read more.
Enhans Launches Global Agentic AI Campaign with Lee Sedol in New York Times Square
Large-scale outdoor advertising to run across New York Times Square, Toronto, and Tokyo Shibuya SAN FRANCISCO, March 6, 2026 /PRNewswire/ — Enhans (CEO Seung-hyun... Read more.
Intensity Therapeutics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
SHELTON, Conn., March 6, 2026 /PRNewswire/ — Intensity Therapeutics, Inc. (“Intensity” or “the Company”) (Nasdaq: INTS), a late-stage... Read more.